Impedimetric Detection of Albumin-Bound Fatty Acids Using Graphene Oxide Electrode

The fatty acid/albumin (FA/Alb) molar ratio is ≤1 in healthy subjects; this ratio can reach 3–4 in patients with acute myocardial ischemia. We describe the spontaneous desorption–adsorption kinetics of FAs from albumin to a graphene electrode at neutral pH. Albumin-depleted human serum was prepared...

Full description

Bibliographic Details
Main Authors: Zihni Onur Uygun, Soner Duman, Ismail Oran
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Chemosensors
Subjects:
Online Access:https://www.mdpi.com/2227-9040/9/9/240
Description
Summary:The fatty acid/albumin (FA/Alb) molar ratio is ≤1 in healthy subjects; this ratio can reach 3–4 in patients with acute myocardial ischemia. We describe the spontaneous desorption–adsorption kinetics of FAs from albumin to a graphene electrode at neutral pH. Albumin-depleted human serum was prepared via ultrafiltration and then mixed with defatted human albumin and sodium oleate at different FA/Alb molar ratios, at a final albumin concentration of 0.6 mM. A commercially available screen-printed graphene oxide (GO)-modified carbon electrode was used for the electrochemical experiments. Frequency-ranged Faradaic electrochemical impedance spectroscopy (EIS) and a single-frequency non-Faradaic impedance measure (chronoimpedance) were used to derive the desorption–adsorption kinetics. The surface of the GO electrode was finally evaluated with the aid of X-ray photoelectron spectroscopy (XPS). With the chronoimpedance experiment, the measured impedance increased accordingly to the FA/Alb ratios. The frequency-ranged EIS showed good linearity between the impedance and the FA/Alb ratio, with a limit of quantification value of 1.06. XPS surface analysis revealed that the FA was adsorbed onto the electrode, with the amount of the adsorbed FA proportional to the FA/Alb ratio. The electrochemical method applied on this peculiar desorption–adsorption kinetics of FAs has the ability to differentiate serum having excess FAs.
ISSN:2227-9040